原发膀胱小细胞癌1例报告并文献分析

J4 ›› 2012, Vol. 11 ›› Issue (3): 52-54.

原发膀胱小细胞癌1例报告并文献分析

目的:报告原发膀胱小细胞癌1例并研究其诊治方法。方法:回顾性分析1例患者的临床和病理资料并结合文献复习讨论。结果:患者以无痛性全程血尿就诊，发现膀胱右侧壁肿块，病检为小细胞癌，免疫组化示神经内分泌标记物Syn、CoA、NSE阳性，行TURBt两月后复发，随即行膀胱全切回肠新膀胱原位排尿术，随访1年无复发和转移。结论:此病少见，恶性程度高，尽管其临床特征同移行细胞癌相同，但治疗方案并无统一意见，治疗需多种手段共同干预，包括手术和放、化疗。

昆明医学院第二附属医院泌肾外科，昆明 650101

收稿日期:2011-12-14 出版日期:2012-03-15 发布日期:2012-03-15
作者简介:李志鹏，主任医师，主要从事泌尿外科研究.

On Primary Small Cell Carcinoma of the Bladder

Department of Urology and Nephrosis, the Second Affiliated Hospital of Kunming Medical College, Kunming 650101, China

Received:2011-12-14 Online:2012-03-15 Published:2012-03-15

摘要/Abstract

摘要：

关键词: 膀胱, 小细胞, 癌

Abstract:

Objective: To report a case of primary small cell carcinoma（SCC）of the bladder and study the diagnosis and treatment.Methods：A retrospective study on clinical and pathological data of a patient with primary small cell carcinoma of the bladder, and a review of the literature on this topic were presented. Results: The outstanding symptom of the case was hematuria. A tumor was located in the right wall of the bladder. On histopathological study, the tumor was characterized by small cell carcinoma, immunohistochemical assay of Syn, EMA and NSE being positive in the tumor tissues. The case underwent TURBt with adjuvant chemotherapy, and there was a small tumor recurrence after 2 months. The case underwent total cystectomy and an ileal orthotopic neo-bladder procedure. After 1 year, there was no evidence for recurrence and metastases. Conclusion: SCC of the urinary bladder is rare, highly aggressive neoplasm, though the clinical and epidemiological characteristics have some similarities with transitional cell carcinoma. Its therapy advice is not yet uniform and its treatment should be multidisciplinary, including surgery, chemotherapy and radiotherapy.

Key words: bladder, small cell, carcinoma

中图分类号:

R737.14

. 原发膀胱小细胞癌1例报告并文献分析[J]. J4, 2012, 11(3): 52-54.

参考文献

〔1〕Trias I，Algaba F，Condom E，et al. Small cell carcinoma of the urinary bladder. Presentation of 23 cases and review of 134 published cases〔J〕. Eur Urol，2001，39（1）:85-90.
〔2〕郭应禄，曾荔.临床泌尿外科病理学〔M〕.北京：北京大学医学出版社，2003:206-207.
〔3〕Liang Cheng，Chong-Xian Pan，Ximing J Yang，et al.Small cell carcinoma of the urinary bladder. A
clinicopathologic analysis of 64 patients〔J〕. Cancer，2004，101（5）:957-962.
〔4〕Mills SE，Wolfe JT，Weiss MA，et al. Small cell undifferentiated carcinoma of the urinary bladder. A
light-microscopic， immunocytochemical， and ultrastructural study of 12 cases〔J〕. Am J Surg Pathol，
1987（11）:606-617.
〔5〕Edward M C，Vos W，De Voogt H J，et al. Small cell carcinoma of the urinary bladder a c1inicopathologic，morphometric，immunohistochemica1 and ultrastructural study of 18 cases〔J〕.Cancer，1989，64:1347-1357.
〔6〕Jones TD， Kernek KM， Yang XJ，et al. Thyroid transcription factor 1 expression in small cell carcinoma of the urinary bladder: an immunohistochemical profile of 44 cases〔J〕. Hum Pathol，2005，36（7）:718-723.
〔7〕Soriano P，Navarro S，Gil M，et al. Small-cell carcinoma of the urinary bladder. A clinico-pathological study of ten cases〔J〕. Virchows Arch，2004，445（3）:292-297.
〔8〕Iczkowski KA，Shanks JH，Bostwick DG，et al. Loss of CD44 variant 6 expression differentiates small cell
carcinoma of urinary bladder from urothelial（transitional cell）carcinoma〔J〕. Histopathology，1998，32（4）:322-327.
〔9〕Edward Karpman，Zelanna Goldberg，Amir Saffarlan，et al. Analysis of treatment for small cell cancer of the bladder and report of three cases〔J〕. Urology，2004，64（3）:494-498.
〔10〕Grignon DJ，Ro JY，Ayala AG，et al. Small cell carcinoma of the urinary bladder. A clinicopathologic
analysis of 22 cases〔J〕. Cancer，1992，69（2）:527-536.
〔11〕Chong-Xian Pan，Ximing J Yang，Antonio Lopez-Beltran，et al.c-kit expression in small cell carcinoma of the urinary bladder: prognostic and therapeutic implications[J]. Mod Path，2005（18）：320-323.

[1]	许家顺，李晓东，杨化，王文磊. 高频超声对＜1 cm乳腺癌及癌前病变精准定位的临床研究[J]. 大理大学学报, 2020, 5(8): 62-64.
[2]	杨文荣，李庄，李爱民，杨利杰，茶剑媛. 肺叶切除术对局部非小细胞肺癌患者右心功能与#br# 生活质量的影响[J]. 大理大学学报, 2020, 5(4): 47-.
[3]	吴春华,李星云,张悦，杨代仙,刘冬岩,杜伟. PPAR-α激动剂WY14643对兔VX2肝癌MMP-9表达的影响[J]. 大理大学学报, 2020, 5(2): 61-64.
[4]	梅雯，孙如丽，李云，熊伟，赵一. 基于数据挖掘分析TOP2A 在胰腺癌中的表达及预后意义[J]. 大理大学学报, 2020, 5(10): 40-47.
[5]	杨改标，李倩，李璇，龚念婷，张胜梅. 血清AFP、B7-H4联合CP检测对原发性肝癌的诊断价值[J]. 大理大学学报, 2020, 5(10): 75-79.
[6]	张建依, 张静, 王剑华, 段赛竹, 张荣生. 阿帕替尼联合放化疗治疗晚期结直肠癌2例并文献复习[J]. , 2019, 4(8): 39-42.
[7]	赖敬业, 陈会永, 赵峰. 腹腔镜与开腹胃癌根治术临床疗效比较研究[J]. , 2019, 4(4): 52-55.
[8]	梅雯，王唯斯，孙美涛，张态，柴蓓蓓，张若鹏，熊伟. 利用TCGA数据集分析人MTERF3基因在子宫颈癌的表达及意义[J]. 大理大学学报, 2019, 4(2): 38-.
[9]	何翠云，周宏伟，吴潇潇，张艳华，李娅萍. 超声诊断甲状腺结节钙化与甲状腺癌相关性分析[J]. 大理大学学报, 2019, 4(2): 79-.
[10]	付海艳, 罗煜, 李红娟, 薛莲, 张洁, 李海雯. 经皮穿刺留置中心静脉导管联合三氧水灌注治疗恶性腹水的临床研究[J]. , 2019, 4(10): 75-78.
[11]	孙美涛，自加吉，陈莹，严长宝，戴莉萍，余敏，熊伟. 利用数据挖掘技术分析HIF-1α 在胃癌中的预后意义[J]. 大理大学学报, 2018, 3(2): 32-37.
[12]	邵宇，舒武英，黎蒙，谭云波. 直肠癌腹腔镜根治术与传统根治术的对比研究[J]. , 2017, 2(8): 31-34.
[13]	李婷，乔婷婷，刘俊勇，沈琦，彭芳. 美洲大蠊提取物逆转Bel-7402/5-Fu多药耐药性实验研究[J]. , 2017, 2(2): 1-5.
[14]	赵娟娟，徐松，向述天，宋芳，段宝凤. 125I粒子食管支架置入治疗食道癌患者的健康宣教[J]. , 2017, 2(2): 80-82.
[15]	曹亚，杨丽春. 乳腺癌超声征象与cerbB-2、Ki67、P53表达之间的相关性研究[J]. J4, 2016, 1(8): 70-75.